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Parkinson’s disease as a system-level disorder
Daniele Caligiore1, Rick C Helmich2, Mark Hallett3, Ahmed A Moustafa4, Lars Timmermann5, Ivan Toni6 and Gianluca Baldassarre1
Traditionally, the basal ganglia have been considered the main brain region implicated in Parkinson’s disease. This single area
perspective gives a restricted clinical picture and limits therapeutic approaches because it ignores the inﬂuence of altered
interactions between the basal ganglia and other cerebral components on Parkinsonian symptoms. In particular, the basal ganglia
work closely in concert with cortex and cerebellum to support motor and cognitive functions. This article proposes a theoretical
framework for understanding Parkinson’s disease as caused by the dysfunction of the entire basal ganglia–cortex–cerebellum
system rather than by the basal ganglia in isolation. In particular, building on recent evidence, we propose that the three key
symptoms of tremor, freezing, and impairments in action sequencing may be explained by considering partially overlapping neural
circuits including basal ganglia, cortical and cerebellar areas. Studying the involvement of this system in Parkinson’s disease is a
crucial step for devising innovative therapeutic approaches targeting it rather than only the basal ganglia. Possible future therapies
based on this different view of the disease are discussed.
npj Parkinson's Disease (2016) 2, 16025; doi:10.1038/npjparkd.2016.25; published online 1 December 2016
INTRODUCTION
Parkinson’s disease (PD) is a neurodegenerative disorder char-
acterized by motor dysfunctions including, among others, tremor,
difﬁculty in initiating and executing voluntary movements
(akinesia/freezing/bradykinesia), muscular rigidity, impaired
execution of movement sequences as well as by non-motor
deﬁcits such as behavioral and cognitive impairments1–3
(Appendix Table 1 presents the abbreviations used in the article).
The motor dysfunctions of PD are thought to result primarily from
the death of dopamine-producing cells in the substantia nigra
pars compacta (SNc), an area in the midbrain mainly targeting the
striatum (Str), which is the input gate of basal ganglia (BG). As a
consequence, PD is characterized by a consistent reduction of
striatal dopamine levels.
Common theoretical and empirical approaches studying PD
directly focus on such BG alterations.4 This view has two important
limitations. First, it limits the understanding of the disease as it
overlooks anatomical and functional interactions between these
nuclei and cerebral cortex/cerebellum. Indeed, BG closely work
with cortex (Ctx) and cerebellum (Cer) to form fundamental
circuitry involved in motor and cognitive tasks of various
complexity, from sensorimotor mapping to reasoning.5–8 There
is strong evidence demonstrating that Cer and BG receive input
from, and send output to, Ctx through multisynaptic anatomically
segregated loops performing distinct functional operations.9,10
Moreover, recent evidence highlights the existence of an
anatomical substrate for a bidirectional communication between
Cer and BG. In this respect, studies on rats11 and monkeys12 have
demonstrated that Cer has a strong disynaptic projection to Str via
the thalamus (Thal). Recent investigations on cebus monkeys have
also shown that the subthalamic nucleus (STN) has a disynaptic
projection to the cerebellar cortex via the pontine nuclei (PN).13
Similar data have recently been found in humans, using diffusion
tensor imaging (DTI).14,15 These data have stimulated new
research directed at investigating the role of Cer and BG in
functions typically associated with cortical areas (e.g., action
understanding7,16,17), and the role of cerebellar and cortical areas
in impairments typically associated with BG, such as Tourette’s
syndrome,18 dystonia,19 and PD.8,20–23
Second, focusing on the BG to study PD limits the approaches
used for therapy as it implicitly suggests acting on such nuclei in
isolation. The most common treatment thus targets the BG and
consists of replenishing dopamine depletion. This approach has
several drawbacks and might produce a variable response for
some motor dysfunctions (e.g., tremor; see refs 20,21,24 for recent
reviews). In addition, dopaminergic stimulation can lead to
dyskinesia,24 impulse control disorders (ICDs),25 and may not
ameliorate or may even worsen non-motor symptoms.3,26–28
This article proposes that investigating the abnormal interac-
tions of the BG–Ctx–Cer integrated system can lead to a better
understanding of PD symptoms and treatments. Figure 1 sum-
marizes the system-level view to the study of PD proposed here.
This view overcomes the limitations of the single area perspective
on PD by supplying a more articulated clinical picture of the
disease, and by paving the way to the study of new therapies
targeting Cer and Ctx alongside the BG.
More in details, we propose that key PD symptoms (tremor,
freezing, action sequencing impairments) can be related to
dysfunctions of speciﬁc, partially overlapping circuits within the
BG–Ctx–Cer system. In particular, we provide support for three
hypotheses: (i) tremor depends on the abnormal interaction
between BG and the Cer–Ctx loops: this hypothesis builds on key
data on the involvement of these loops in tremor20,21,29 and on
the recently discovered STN–Cer disynaptic connection;13 (ii)
freezing is linked to abnormal interactions between the BG
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pathways, the presupplementary motor area (pre-SMA) and Cer–
Str disynaptic link:12 this hypothesis builds on evidence showing
the inﬂuence of pre-SMA30,31 and Cer31,32 on freezing; (iii)
dysfunctions in the circuit linking Cer to SMA, and in the
hyperdirect pathway linking SMA with STN, may have a role in
action sequencing impairments: this hypothesis is based on data
showing the contribution of pre-SMA/SMA,33,34 Cer17,35 and
BG36,37 in action sequences and on recent evidence on pre-
SMA/SMA role in PD.38,39 We also furnish some more general
indications on how the view proposed here might contribute to
advance our understanding of other motor and non-motor
features of PD. The complexity of the cortical and subcortical
circuits underlying PD deﬁcits suggests using dynamical multi-
scale computational models to capture its quantitative aspects
and to integrate data from multiple sources, such as different
brain imaging techniques. This opens up the possibility to design
new procedures for monitoring and treating the disease, that
focus on the whole BG–Ctx–Cer system rather than BG in isolation.
THE NEURAL SYSTEM UNDERLYING PD
To illustrate with speciﬁc cases the utility of the proposed
perspective to better understand proximal causes of PD, in this
section we explain how three partially overlapping cortical–
subcortical circuits may underlie three important PD symptoms.
Figure 2 shows some key components of the BG–Ctx–Cer system
that are important to study the three symptoms. The schema is
not exhaustive of all the possible connections between basal
ganglia, cortical, and cerebellar areas. Rather, it focuses on the
connections that may have a major role in the three PD symptoms
considered here. This is the reason why, for example, the ﬁgure
indicates SMA/pre-SMA as the only sources of the hyperdirect
pathway from cortex to STN, omitting the projections from M1 to
STN. The same considerations hold for the Figures 3, 4, 5, which
are derived from Figure 2. The other pathways not considered
here might have roles in other aspects of PD symptoms.
The cerebral network underlying Parkinson’s tremor
The occurrence of resting tremor in PD is probably related to the
death of SNc dopamine-containing cells. PD tremor mainly
involves dysfunctions in the system formed by the motor cortex,
cerebellum, thalamus, and basal ganglia.40–42 Patients with
tremor-dominant PD show an increased functional connectivity
between BG and the cerebello-thalamo-cortical circuit.29 This
evidence suggests that PD tremor may result from a pathological
interaction between BG and the cerebello-thalamo-cortical circuit
(Cer–Thal–M1). However, the speciﬁc mechanisms underlying
such pathological interaction are still widely debated.43
Several hypotheses have been proposed to explain the
occurrence of tremor in PD (see ref. 20 for an overview). Most of
these have largely focused on locating the tremor pacemaker in
thalamus44 or BG,45 or in pallido-thalamic interactions.46 As
underlined in ref. 20, these hypotheses are unable to explain
the involvement of both cerebello-thalamo-cortical system and BG
in PD resting tremor.40,41 To address this issue, Helmich et al. have
recently proposed a system-level explanation of PD resting tremor
called the “dimmer-switch” hypothesis.20,29 According to this
hypothesis, BG work analogously to a light switch that triggers
tremor-related responses in the Cer–Thal–M1 circuit and this, in
turn, generates tremor modulating its intensity like a light dimmer.
Figure 1. Graphical summary of the systems-level view to the study
of PD proposed in this article. Pivoting on evidence supporting the
integrated nature of BG, Ctx, and Cer, largely interacting through
Thal, and the involvement of Cer and Ctx in PD, the view urges
studying PD by focusing on the BG–Ctx–Cer system rather than on
BG in isolation. Studying how such system affects PD is a crucial step
to draw a more articulated clinical picture of the disease and to
devise innovative therapeutic approaches. BG, basal ganglia; Cer,
cerebellum; Ctx, cortex; PD, Parkinson’s disease.
Figure 2. Schema of the basal ganglia-cortical-cerebellar (BG–Ctx–
Cer) system involved in three PD motor symptoms, in particular
tremor, freezing, and action sequence impairments. The arrows
indicate glutamatergic excitatory connections whereas lines ending
with a ﬁlled circle represent inhibitory GABAergic projections. The
bidirectional arrows linking Thal and Ctx include both the BG-
cortical and the cerebellar-cortical channels (note that Cer sectors
within Thal could be partially overlapped with those of BG,
see Ref. 141 for more details). The dashed lines within Thal represent
the cerebellar target sectors within Thal through which the Cer
reaches Str.12,13 BG, basal ganglia; Cer, cerebellum; Ctx, cortex; GPe,
external globus pallidus; GPi, internal globus pallidus; M1, primary
motor cortex; PPN, pedunculopontine nucleus; PN, pontine nuclei;
pre-SMA, pre-supplementary motor area; Str, striatum; STN, sub-
thalamic nucleus; SNr, substantia nigra pars reticulata; SNc,
substantia nigra pars compacta; SMA, supplementary motor area;
Thal, thalamus.
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This hypothesis is in line with previous theoretical proposals
highlighting the role of BG for movement initiation and of Cer for
movement ampliﬁcation,47 and represents an important attempt
to account for tremor in PD through a system-level perspective.
However, this hypothesis does not specify how BG could
interact with the Cer–Thal–M1 circuit to switch on tremor. Here
we extend the dimmer-switch model by highlighting possible
pathways through which BG could interact with the Cer–Thal–M1
circuit (Figure 3).
We hypothesize that the main axis involved in producing
tremor is the Thal–Ctx system including both the BG–Thal–M1 and
the Cer–Thal–M1 circuits. This hypothesis is based on previous
studies showing that thalamo-cortical functional connectivity
distinguishes pathological tremor from mimicked tremor,48 that
dopamine speciﬁcally reduces thalamo-cortical coherence in PD
tremor,49 and that Thal has strong rhythmic properties capable of
driving the tremor on a cycle-by-cycle basis.50 The BG are
connected with the thalamo-cortical system via the direct and
indirect pathways that exert a net inhibitory inﬂuence onto Thal
through GPi. Thal, in turn, is bi-directionally connected with M1
through excitatory links. In non-pathological conditions, the
inhibition of speciﬁc output nuclei of BG leads to increased
activity within the circuits linking Thal with M1 allowing the
focused facilitation of speciﬁc motor patterns.51 Through these
pathways, BG–Thal–M1 and Cer–Thal–M1 circuit converge at the
level of M1.7,10 Speciﬁcally, GPi sends GABAergic projections to the
anterior part of the ventrolateral Thal which in turn sends
excitatory efferents to the M1. M1 projects to the posterior part
of the ventrolateral Thal that also receives cerebellar projections.52
This hypothesis would explain why deep brain stimulation (DBS)
of STN, GPi, and Thal ventral intermediate nucleus (VIM, which is a
target of cerebellar efferents) are all effective in treating
tremor.53–55
Another hypothesis is that the recently discovered STN-
cerebellar cortex anatomical link through the pontine nuclei13
may have an important role in PD tremor by inﬂuencing the
dysfunctional interaction between BG and the thalamo-cortical
system. In particular, we propose that the subthalamic-pons-
cerebellar circuit (STN–PN–Cer)13 may be considered as a further
pathway, alongside the traditional ones (direct, indirect, and
hyperdirect pathways), which allows the BG to inﬂuence the
excitability of the thalamo-cortical system through Cer. We term
this the “hyper-indirect pathway”. The projections from STN to PN,
and from PN to granule cells of cerebellar cortex, are long-range
and therefore probably glutamatergic.13 Increased STN activity, as
found in PD,56 would thus excite the cerebellar cortex, which in
turn has an inhibitory inﬂuence onto the deep cerebellar nuclei.57
Further investigations are needed to conﬁrm this hypothesis as
there is no direct evidence supporting the impact of STN
descending glutamatergic projections on PN and cerebellar
neurons. As the deep cerebellar nuclei have glutamatergic
projections to the VIM (cerebellar thalamus; refs 58,59), the net
result would be inhibition of the thalamo-motor system. In vitro
studies have shown that hyperpolarization of single thalamic
neurons turns these neurons into single-cell oscillators with a
ﬁring frequency of about 6 Hz, which is the resting tremor
frequency in PD.50 In PD, changes in the inﬂuence of the
direct/indirect pathways, the “hyper-indirect” pathway, or the
balance between them, onto the thalamo-motor system, may be
responsible for triggering rhythmic activity in the Cer–Thal–M1
circuit. A recent dynamic causal modeling functional MRI (fMRI)
study in tremor-dominant PD tested how tremor-related activity is
transmitted from the basal ganglia toward the cerebello-thalamo-
cortical circuit, comparing the contribution of the two pathways
outlined above. The ﬁndings suggest that tremulous activity ﬁrst
arises in the GPi, and is then propagated through effective
connectivity from the GPi toward the motor cortex (rather than
the hyper-indirect pathway from STN to Cer60). After the onset of
tremor, tremor-related peripheral inﬂuences onto Cer may
further modulate processing within the Cer–Thal–M1 circuit,
having a role in maintaining the tremor once it has been
triggered by the BG.61
Support for our cortical–subcortical circuit hypothesis
underlying tremor comes also from analysis of the tremor-
related activity in the areas considered in Figure 3 (refs 21,62).
Overall, on the methodological side this analysis shows how a
system-level perspective is needed to disentangle the complex
involvement of different neural circuits in the production of PD
tremor.
Figure 4. Cortical–subcortical circuit possibly underlying Parkinson’s
disease (PD) freezing. The red arrows indicate the anatomical
pathways through which the elements of the cortical–subcortical
system interact between them to produce freezing.
Figure 3. Cortical–subcortical circuit underlying Parkinson’s disease
(PD) tremor. The red arrows indicate the anatomical pathways
through which the elements of the cortical–subcortical system may
interact to produce tremor in PD.
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Freezing as response conﬂict impairment: cortical–subcortical
substrates
Freezing is the inability to begin or continue a voluntary discrete
or rhythmic movement. It can affect walking, writing, speech, and
is also associated with deﬁcits in a number of executive functions
including attention and conﬂict resolution.63–66 The vast range of
conditions provoking or relieving freezing supports the involve-
ment of a complex brain network including both cortical and
subcortical areas.65,67
Pivoting on the anatomical connections between BG and Ctx8,10
and between BG and Cer,13,14, and on recent data about the
involvement of pre-SMA30,31,63,68 and Cer31,32,63 in freezing, we
propose here some system-level hypotheses on the possible
alterations of cortical–subcortical circuits that might underlie
freezing (Figure 4). Striatum modulates the output nuclei of BG
through two pathways. The ﬁrst is the direct pathway that involves
a Str GABAergic connection directly inhibiting GPi and substantia
nigra pars reticulata (SNr). The second is the indirect pathway
involving two sub-routes: the short indirect pathway, linking the
external globus pallidus (GPe) to GPi/SNr via GABAergic connec-
tions; and the long indirect pathway linking GPe to STN which in
turn projects to GPi/SNr.69
Low dopamine levels in PD lead to a reduction in the strength
of striatal inhibition to GPi/SNr and an increase in striatal inhibition
of GPe. A lower activation of GPe, in turn, results in an increased
GPi/SNr inhibitory output both via the Str–GPe–GPi/SNr short
indirect pathway and via the Str–GPe–STN–GPi/SNr long indirect
pathway.2 The GPi/SNr abnormal inhibition of BG target areas is
relevant for the manifestation of multiple PD symptoms including
freezing.2,30 In particular, this inhibition affects Thal–M1 circuits
subserving the performance of discrete voluntary movements.70
Moreover, this inhibition might abnormally inhibit pre-SMA and
SMA, namely cortical areas that have a critical role in the initiation,
sequencing and termination of movements.33,34,38 These areas
have been often found to be underactivated in PD patients,30,31
putatively because as other thalamo-cortical areas they receive an
abnormal inhibition from BG,22,23 or due to other internal
disregulations.30,68 In addition, an increase of inhibitory output
onto the dorsal pedunculopontine nucleus (PPN) and Thal might
contribute to freezing of rhythmic motor behaviors,32,71 such as
walking, due to the PPN efferent connectivity to the central
pattern generators of the spinal cord coordinating the alternating
activity of ﬂexor/extensor muscles.72–75 The involvement of PPN in
freezing is indirectly supported by recent data showing that PPN
DBS may reduce freezing of gait in PD patients.76 Further, PPN
receives inputs from STN, GPi and SNr77 and projects into the STN,
SNc, GPi, Cer, spinal cord, and SMA.77,78 In general, PPN can have a
role in motor modulation and in the initiation and maintenance of
locomotion.79 In PD patients it has been shown that PPN activity
changes during movement preparation and execution.80 Building
on recent data,81 we propose that PPN may abnormally regulate
STN activity through the Cer–Thal–Str pathway, thus further
augmenting freezing. Indeed, recent evidence shows that
stimulation of PPN may inﬂuence Cer activity.32,78,82 The inﬂuence
of PPN on Cer may in turn increase BG output by regulating STN
activation through the Cer-Thal-Str newly discovered pathway6,12
and the Str–GPe–STN–GPi/SNr long indirect pathway considered
above. A reduced cerebellar connectivity with other areas
involved in motor control31 might also lead to a lack of on-the-
ﬂy corrections of posture and gait causing balance problems and
walking abnormalities.83 A reduced coordination of steps during
challenging gait phases, such as turning, may precipitate
freezing.63
Action sequencing impairment as deﬁcit in timing: cortical–
subcortical substrates
PD patients have a difﬁculty in performing action sequences,
including completing sequences of heterogeneous movements in
correct order.84,85 Here we discuss a cortical–subcortical circuit
that may underlie this symptom. The circuit, shown on Figure 5, is
mainly based on data supporting the contribution of pre-SMA,
SMA, Cer and BG in managing action sequences.17,33,36,37 Different
types of neurons in pre-SMA and SMA help to encode not only
where in a sequence the action is but also the conditional links
between the previous response and the upcoming response, often
in a highly speciﬁc manner.38 In this respect, it has been shown
that pre-SMA and SMA neurons respond before some sequences
(e.g., turn-pull-push a lever) but not others (e.g., turn-push-pull),34
that some neurons of pre-SMA and SMA respond only to the rank
order of a movement in the sequence (e.g., only before the second
movement regardless of what the movement is),86 and that pre-
SMA and SMA cells also encode the number of movements that
remain to be made to complete a sequence to obtain a reward.87
As both pre-SMA and SMA are anatomically linked to Cer
through Thal,88 Cer could assist pre-SMA and SMA by contributing
to the anticipatory activation of the neurons of these cortical
regions during action sequences. In particular, pre-SMA and SMA,
working in synergy with Cer, may possess the capacity of
anticipating future events at fast temporal scales based on
forward models.7,35 This view is in line with the “timing
hypothesis” of cerebellar function postulating that Cer is critical
for representing the temporal relationship between task-relevant
events as it works as a general “timing co-processor” whose effect
depends on the targeted centres.89 The circuits linking BG with
pre-SMA and SMA may also support the processes underlying
action sequencing. In more detail, the activation of pre-SMA and
SMA neurons could regulate, in an anticipatory fashion with
respect to the next movement, the activation of STN though the
hyperdirect pathway. This pathway, in turn, conveys the signal
from motor-related cortical areas (in this case pre-SMA and SMA)
to the globus pallidus, bypassing the striatum, with shorter
conduction time than the signal conveyed through the striatum.90
The anticipatory activation of STN could indirectly support the
anticipatory activation of the next movement by fostering
the movement selection processes through the direct pathway
of BG.2,51
Figure 5. Cortical–subcortical circuit possibly underlying Parkinson’s
disease (PD) action sequencing impairments. The red arrows
indicate the anatomical pathways through which the elements of
the cortical–subcortical system interact between them to produce
action sequencing impairments.
Parkinson’s disease: a system-level disorder
D Caligiore et al
4
npj Parkinson's Disease (2016) 16025 Published in partnership with the Parkinsonâ s Disease Foundation
These neural processes might be dysregulated in PD. In
particular, in the circuit shown in Figure 5 the triggering event
leading to an action sequencing impairment may be related to the
malfunctioning of the BG-preSMA/SMA circuit, caused by dopa-
mine dysregulation, and this might propagate to the Cer–Thal–
pre-SMA/SMA circuits, which support the timing aspects of pre-
SMA/SMA functioning.34,38,86 As a consequence, pre-SMA and SMA
neurons may not regulate as needed the activation of STN
through the hyperdirect pathway. In turn, the lack of anticipatory
activation of STN may fail to support the activation of the next
movement, thus producing impaired action sequencing.
A system-level view of other PD symptoms
A system-level perspective might also help to disentangle unclear
aspects related to other PD symptoms, although for these a
formulation of hypotheses as articulated as those proposed for
tremor, freezing and action sequences requires further investiga-
tions. Akinesia, for example, has been linked to the increased
inhibitory BG output. Indeed, DBS applied to the globus pallidus
has been shown to reduce akinesia symptoms in Parkinsonian
monkey models.21,91 It has also been shown that beta band
activity in the STN correlates with akinesia in PD, and that the
clinical improvements following DBS of STN can affect both
akinesia and rigidity.92 Further, transcranial stimulation reduces
rigidity in PD patients suggesting a role for the cortico-spinal
pathway.21,92 It has also been found that the Cer is overactive in
PD patients with akinesia in comparison with healthy controls,
suggesting that the Cer may have a compensatory role.21
However, it is not clear through which neural pathways Cer can
enhance movement speed and reduce akinesia although one
might expect this to involve the Cer–Ctx loops and the
aforementioned newly discovered Cer–Thal–BG pathway.12 It is
also unclear how to integrate the role of the Cer as a
compensatory system and as a motor timing system,21 but it is
expected that an explanation has to involve system-level
mechanisms.
In the same line, a system-level perspective involving cortical–
subcortical brain regions could be used to characterize non-motor
deﬁcits in PD. One example is ICDs, which include pathological
gambling, compulsive eating, and hypersexuality.93 ICDs might be
caused by an overstimulation of D2 receptors.25 Impulsivity can
also be caused by STN DBS.94 Like motor symptoms discussed
above, ICDs in PD are also associated with cortical and subcortical
dysfunctions.95 Besides the indirect pathway including STN, other
studies found that the nucleus accumbens also has a role in the
occurrence of ICDs.96 Other neural studies have implicated other
brain regions including the hippocampus,97 prefrontal cortex,98
and amygdala.95 ICDs in PD have been shown to be related to PD
motor impairment, for example, patients with gait impairment
show more impulsive behavior than tremor-dominant patients.99
One study also found that motor complications are more common
in PD patients with ICDs than in patients without ICDs.100
Inducing anxiety was found to exacerbate freezing of gait in PD
patients.101 Further, prefrontal-based processes, including
attentional control, executive function, and working memory,
were shown to impact successful upper and lower limb motor
control.102,103 Clinical and functional imaging studies suggest
that cognitive symptoms in PD might be linked to the
involvement of prefrontal, premotor and parietal regions,23,27,39
hippocampus,26,104 and amygdala.28 In addition, increasing
evidence suggests that the cognitive decline reported in PD
patients is not simply related to a mere dopaminergic deﬁcit.105
Indeed, neurodegeneration in PD, besides affecting SNc dopami-
nergic neurons, also appears in serotonergic neurons in the raphe
nuclei,106 noradrenergic neurons in the locus coeruleus,107 and in
cholinergic neurons in the basal forebrain complex.108 An
enhanced neural architecture accounting for system-level
balancing of dopamine, noradrenaline, serotonin, and acetylcho-
line could help understand the roles played by these neuromo-
dulators in PD non-motor deﬁcits. Overall, this evidence suggests
that extending the system-level schema proposed here to include
other key cortical and subcortical areas relevant for motor and
cognitive control109,110 could be useful for understanding non-
motor deﬁcits associated with PD and their relationship with
motor dysfunctions.4,111–113
From theory to computational models of the BG–Ctx–Cer system
imparements in PD
The brain system proposed in Figure 2 as the cortical–subcortical
network producing PD symptoms has a clear, distinct feature: it
involves highly recurrent circuits. In this article, we aimed to link
PD symptoms to speciﬁc impairments of the network, but this
exercise has an inherently limited scope: it can only partially
disentangle the circular causations involved by the above-
discussed circuits, and on this basis offer quantitative predictions.
For example, we proposed speciﬁc hypotheses to explain tremor
and freezing, but it is not possible to establish if such hypotheses
are self-consistent and sound only on a verbal basis. Computa-
tional models have the power to prove the self-consistency of
hypothesis as those proposed here.4,51,69,94,109,114 This is a
necessary condition to establish the validity of theories (although
it is not sufﬁcient and has to be followed by empirical
examinations). For this reason, we consider here possible
approaches to follow to translate the verbal theories presented
here into operational computational models able to offer sound
explanations and quantitative predictions on PD symptoms.
The models used to this purpose should have two key
ingredients. First, to be able to capture the local and global
dynamic functioning of the brain neural systems involved in PD
they should be multi-scale models.109,115 Models in computational
neuroscience often deal with a single-scale description that
corresponds to a particular anatomical scale; for example, the
cellular scale, the microcircuit scale, the meso-level (e.g.,
the relations between BG nuclei), and the system-level (e.g., the
BG–Thal–Ctx–Cer system). In particular, a deeper understanding of
PD will come only from analyses and models spanning multiple
spatial and temporal scales. Indeed, striatal dopamine loss can be
described at the cellular level, but PD symptoms can be
understood only by tracing the effects of such loss onto the
micro-/meso-circuits of BG and how such effects reverberate onto
the BG–Ctx–Cer system. To this purpose, computational model
components with high anatomical detail could be embedded
within more abstract cortical–subcortical model components.115
For example, a detailed model formed by conductance-based
neurons might be integrated into the striatal microcircuit. This, in
turn, could be embedded in a spiking neuron model of the
BG–Ctx–Cer. In this way, phenomena happening at the lowest
level of the embedded hierarchy—where the dysfunctional
pathology of PD originates—may cascade upwards to affect
upper levels of the hierarchy.116
Second, computational models of the PD cortical–subcortical
network should capture the dynamical events characterized by
circular causality involving the cortical–subcortical network. In this
respect, it has been proposed that the fundamental information
processing happening within (and between) BG, Ctx and Cer are
highly dynamic and so can be captured only through highly
dynamic computational models (e.g., BG: Refs, 114,116; Ctx:
Refs, 117,118; Cer: Refs, 89,119). Capturing such dynamic
processes with quantitative models will lead to a deep under-
standing of the interplay of cortical/sub-cortical areas and how
they might be altered in PD, thus supporting the development of
new monitoring techniques and therapies.
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NEW APPROACHES FOR MONITORING AND TREATING PD
The system-level view of PD features has a high potential for the
development of innovative procedures for monitoring and
treating PD. We show this by illustrating some of these
possibilities. Regarding monitoring, one of the biggest future
challenges for imaging techniques applied to PD is to integrate
their results to identify the mechanisms that might be targeted
with drugs and other interventions.3,120,121
The dynamic multiscale computational models discussed in the
previous section could support the integration of the data
acquired with different techniques based on their capacity to
incorporate information at different levels. At the system- and
meso-level, the models could integrate data from resting-state
functional magnetic resonance imaging (rsfMRI), structural mag-
netic resonance imaging (sMRI), arterial spin labeling (ASL) on the
BG–Ctx–Cer overall activity. These techniques could be used to
measure parameters related to the entire BG–Ctx–Cer network122
and this information could be used to constrain the overall
architecture of the model. Recent fMRI analysis techniques, such
as dynamic causal modeling,123 use Bayesian statistics to system-
atically compare the evidence for different functional network
conﬁgurations underlying different behaviors.124 These methods
have been used for example to test the circuit-level inﬂuences of
STN-DBS in PD,125 or the circuit-level changes underlying
dyskinesias126 and bradykinesia.127 Another method is to use
functional network connectivity analyses to reveal connectivity
patterns among different brain regions.123 Using these techniques
it has been found that the disconnection between the prefrontal
cortex and BG in PD could explain some aspects of freezing of
gait.128 Techniques returning more detailed information on the
actual anatomical connectivity, such as DTI, could be used to
further constrain the model architecture. DTI has been extensively
used with healthy human subjects to investigate BG–Ctx
connectivity patterns129 and so it might be used to also furnish
data on Cer–Ctx and Cer–BG connections in both healthy and PD
subjects. Linked to this, 18F-ﬂuorodeoxyglucose positron emission
tomography (PET) has shown changes in Cer and Ctx connectivity
patterns in relation to tremor in PD.130 DTI could also furnish
information on the internal connectivity of areas, for example
within the BG.131 At the micro-circuit and cellular level, data on
dopamine production and receptors from PET and from dopamine
transporter-single photon emission computed tomography
(DAT-SPECT) could be used to set the model parameters so as
to capture speciﬁc PD damages.
By disentangling the multifaceted mechanisms underlying PD
symptoms, the system view of PD proposed here, operationalized
into dynamical system-level models integrating multi-source data,
could lead to a systematic data-driven improvement of
therapies.120,132 We support this possibility by referring to some
relevant treatment techniques. DBS and transcranial magnetic
stimulation (TMS) have been used with various brain targets, in
particular sites involving areas of the BG–Ctx–Cer system and not
only BG. Indeed, several experiments support the idea that DBS
preferentially modulates remote structures rather than local
circuits since ﬁbers of passage are more excitable than local cell
bodies at the site of stimulation.133 The analysis of the cortical–
subcortical circuits discussed above, possibly supported by
computational models integrating multiple data sources, could
represent a necessary step to better understand the mechanisms
underlying DBS/TMS effects and so to identify possible new
targets within the BG–Ctx–Cer system.
Regarding tremor, the literature suggests that this symptom can
have a variable responsiveness to dopamine treatments.20,21,24
Alternative effective therapies for tremor are based on DBS of STN,
of the posterior subthalamic area, and of the thalamic ventral
intermediate nucleus.53–55 The improvements in tremor after DBS
of STN could be indirectly related to a modulation of the Cer
activation as suggested by several imaging studies reporting
metabolic changes in Cer during DBS of STN.21,134 In general, it has
been shown that the efﬁcacy of DBS for treating tremor may be
improved when taking interregional structural or functional
connectivity of BG, Cer, Thal, and M1 into account.58 The circuit
shown in Figure 3 supports this perspective by providing a
hypothesis on how the STN-Cer–Thal–M1 and the STN–GPi/SNr–
Thal–M1 circuits may interact during tremor. Moreover, the
analysis of this circuit suggests that it is important to further
investigate how the stimulation of Cer (for example, through
TMS)21 and M1 (e.g., with rTMS135) may affect tremor, and whether
functional uncoupling of BG from the Cer–Thal–M1 circuit could
reduce tremor.
The lack of fundamental understanding of the neural mechan-
isms underlying freezing limits current therapeutic options.
Freezing is weakly responsive to dopaminergic medication30 and
also shows a variable response to DBS therapy targeting either
GPi, STN or PPN.136 In this respect, there are data showing that
STN of GPi DBS are not effective in reducing freezing of gait,
although preliminary evidence suggests that PPN DBS may reduce
it.76,136 The circuit shown in Figure 4 suggests that alternative
target areas for the treatment of freezing in PD could be the Cer or
pre-SMA. This would be supported by various recent studies
showing reduction of dyskinesia137 and improvements in
handwriting138 in PD patients after TMS stimulation of SMA
circuits. These data may provide the foundation for a larger
investigation of the effects of noninvasive brain stimulation over
the pre-SMA and SMA in individuals with PD.
Multi-scale and dynamical computational modeling studies can
simultaneously investigate potential treatments for tremor,
freezing, and action sequencing impairments. This approach
could provide a breakthrough in devising new therapies for PD
as it could allow testing drug effects (and collateral effects) in
simulation (https://ec.europa.eu/digital-agenda/en/virtual-physio
logical-human and see also the EU research project NoTremor:
http://notremor.eu/notremor/) and use them to select the most
promising therapeutic interventions that produce the simulta-
neous reduction of several symptoms while reducing side effects.
This paves the way to the development of even more
innovative therapeutic approaches. PD symptoms are highly
variable in different patients and we currently lack widely-
accepted systematic ways to adapt therapies and medications to
them.1,3 The adoption of a system-level view of PD features,
supported by multi-scale models, could be the necessary step to
trace individual brain differences underlying different patients
subtypes, for example tremor-dominant versus akynetic-rigid.20,21
This knowledge would thus furnish an invaluable basis on which
to tailor interventions on the speciﬁc features and conditions of
the speciﬁc patient.
CONCLUSIONS
After Alzheimer’s disease, PD is the most common neurodegen-
erative disorder worldwide. It primarily affects the elderly and thus
due to population aging it has become a rapidly growing area of
concern. Owing to the high prevalence of the disease (about 6.3
million people around the world) the limitations of pharma-
cotherapy and neurosurgery remedies, and the social and
economic burden of PD,24,139,140 innovative approaches to the
study and treatment of PD are needed. We argue here that to
strengthen our understanding of the wide spectrum and
variability of PD motor symptoms we need to address how
dopamine dysregulation reverberates on the whole BG–Ctx–Cer
system. This broader perspective allows for understanding the
dopamine-related causes of PD symptoms as linked to the circular
dynamic relations involving the meso-level multiple circuits within
BG, Cer and Ctx and their reciprocal interactions at the level of the
whole system. This perspective also supports the identiﬁcation of
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new possible disease monitoring processes and therapeutic
interventions, for example, the identiﬁcation of new targets for
DBS and TMS, a model-based guidance of brain imaging
techniques to follow the disease evolution, and a more informed
solution of drug-related side effects concerning psychiatric and
cognitive disorders.
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APPENDIX
Table 1. Main abbreviations used in the article
ASL Arterial spin labeling PN Pontine nuclei
BG Basal ganglia PPN Pedunculopontine nucleus
Cer Cerebellum pre-SMA Pre-supplementary motor area
Ctx Cortex rsfMRI resting-state functional magnetic resonance imaging
DAT-SPECT Dopamine transporter-single photon emission computed tomography rTMS Repetitive transcranial magnetic stimulation
DBS Deep brain stimulation sMRI structural magnetic resonance imaging
DTI Diffusion tensor imaging SMA Supplementary motor area
GPe External globus pallidus SNc Substantia nigra pars compacta
GPi Internal globus pallidus SNr Substantia nigra pars reticulata
ICDs Impulse control disorders STN Subthalamic nucleus
M1 Primary motor cortex Str Striatum
PET Positron emission tomography Thal Thalamus
PD Parkinson’s disease TMS Transcranial magnetic stimulation
PFC Prefrontal cortex VIM Ventral intermediate nucleus of thalamus
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